Scott Tykodi, MD, PhD

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    clinical research
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    10/31/2026
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AVEO Oncology
    Topic:
    clinical research
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    04/30/2026
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    clinical research
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    06/30/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Exelixis
    Topic:
    clinical research
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    05/31/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    clinical research
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    03/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    advisory board
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    10/07/2021
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Targeted Oncology
    Topic:
    Regional CME virtual presentation
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    02/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    FirstWord
    Topic:
    phone interview
    Date added:
    03/05/2023
    Date updated:
    08/03/2023
    Relationship end date:
    07/13/2022
Return to 2023 Cancer Immunotherapy Summit: Everything, Everywhere, All At Once of Cancer Immunotherapy